Clinical events leading to the progression of heart failure: Insights from a national database of hospital discharges

European Heart Journal

Volumn 22, Issue 2, 2001, Pages 153-164

  Khand, A U ^a   Gemmell, I ^b   Rankin, A C ^a   Cleland, John G F ^c  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Atrial fibrillation; Epidemiology; Heart failure; Ischaemic heart disease; Left ventricular remodelling

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; RISK FACTOR;

ADULT; AGED; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0034944839     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2175     Document Type: Article

References (58)

1. Trends in hospitalisation for heart failure in Scotland 1980-1990
2. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995
3. Cardiovascular disease in the Netherlands, 1975 to 1995: Decline in mortality, but increasing numbers of patients with chronic conditions
4. Effects of enalapril on mortality in severe congestive heart failure. Results of the Coperative North Scandinavian Enalapril Survival Study (CONSENSUS)
5. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
6. The cardiac insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
7. Effect of ramipril and morbidity of surviviors of acute myocardial infarction with clinical evidence of heart failure
8. Is the prognosis of heart failure improving?
9. Effect of left ventricular sphericity on the evolution of ventricular dysfunction in rats with diffuse isoproteronol-induced myocardial necrosis
10. Angio-converting enzyme inhibition after myocardial infarction: The Trandolapril Cardiac Evaluation Study
11. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: Baseline predictors and impact of long-term use of captopril: Information from the Survival and Ventricular Enlargement (SAVE) trial
12. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
13. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
14. Effects of captopril on ischaemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial SAVE Investigators
15. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection
16. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure
17. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks
18. Early readmission of elderly patients with congestive heart failure
19. Critical event pathways for progression of heart failure and mortality: Insights from the ATLAS study
20. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions congestive heart failure
21. Prevention of worsening heart failure: Future focus
22. Ventricular remodeling and its prevention in the treatment of heart failure
23. Prevention of heart failure progression: Current approaches
24. Incidence and aetiology of heart failure, A population-based study
25. The Scottish Record Linkage System
26. Quality of Scottish Morbidity Record (SMR) data
27. The West of Scotland Coronary Prevention Group: Computerised record linkage compared with traditional patients follow-up methods in clinical trials and illustrated in a prospective epidemiological study
28. Concomitant factors of decompensation in chronic heart failure
29. Readmission after hospitalization for congestive heart failure among medicare beneficiaries
30. Hospital readmissions among the elderly
31. Prevention of relapse in patients with congestive heart failure: The role of precipitating factors
32. Heart failure and atrial fibrillation: Current concepts and controversies
33. Risk stratification in chronic heart failure
34. Systematic review of the management of atrial fibrillation in patients with heart failure
35. The epidemiology of heart failure: The Framingham Study
36. The epidemiology of heart failure
37. How accurate are SMR 1 (Scottish Morbidity Record 1)
38. Errors in diagnostic returns
39. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992
40. Cause of death in clinical research
41. Mode of death in chronic heart failure: A request for more accurate classification
42. Sudden death in heart failure: Vascular or electrical?
43. Ischaemia as a 'trigger' for sudden death in patients with cardiomyopathy and heart failure secondary to coronary artery disease: Results from the ATLAS trial
44. Heart failure progression due to secondary organ dysfunction in acute heart failure
45. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients
46. Improved knowledge of antidiabetic treatment - A necessity for the modern cardiologist
47. Preventable causative factors leading to hospital admission with decompensated heart failure
48. Early readmission of elderly patients with congestive heart failure
49. Trandolapril reduces incidence of atrial fibrillation following acute myocardial infarction
50. Effects of carvedilol, a vasodilator beta-blocker, in patients with congestive heart failure due to ischaemic heart disease
51. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1
52. The effects of spironolactone on morbidity and mortality in patients with severe heart failure
53. Dofetilide in the treatment of atrial fibrillation in patients with impaired left ventricular function: Atrial Fibrillation in the DIAMOND study
54. Oral amiodarone increases efficacy of DC cardioversion in patients with chronic atrial fibrillation and organic heart disease
55. Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodarone
56. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation
57. The WASH study (Warfarin/Aspirin Study in Heart Failure) rationale, design and end-points